Literature DB >> 2069414

Soluble interleukin-2 receptors and psoriasis.

R Dummer1, F G Dunkel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069414     DOI: 10.1007/BF00371625

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  11 in total

1.  Activation of the alternative pathway of complement in psoriatic lesional skin.

Authors:  H Takematsu; H Tagami
Journal:  Dermatologica       Date:  1990

2.  HLA-DR antigen expression on keratinocytes in highly inflamed parts of psoriatic lesions.

Authors:  T Terui; S Aiba; T Kato; T Tanaka; H Tagami
Journal:  Br J Dermatol       Date:  1987-01       Impact factor: 9.302

3.  Assessment of the activation pathways of the complement in psoriatic patients by use of complement fragment C4d and Bb measurements.

Authors:  H Takematsu; H Tagami
Journal:  Dermatologica       Date:  1989

4.  Interleukin-2 receptor expression in human mast cells and basophils.

Authors:  N Maggiano; F Colotta; F Castellino; R Ricci; S Valitutti; L M Larocca; P Musiani
Journal:  Int Arch Allergy Appl Immunol       Date:  1990

5.  Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin.

Authors:  H Takematsu; H Tagami
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

6.  Determination of anaphylatoxin concentrations in suction blisters in patients with psoriasis.

Authors:  K Ohkohchi; H Takematsu; H Tagami
Journal:  J Invest Dermatol       Date:  1986-07       Impact factor: 8.551

Review 7.  Immunologic mechanisms in psoriasis.

Authors:  A B Gottlieb
Journal:  J Am Acad Dermatol       Date:  1988-06       Impact factor: 11.527

8.  Increased C5a anaphylatoxin in the sera of psoriatic patients and patients with inflammatory dermatoses.

Authors:  K Ohkohchi; H Takematsu; H Tagami
Journal:  J Dermatol       Date:  1986-08       Impact factor: 4.005

9.  Increased anaphylatoxins (C3a and C4a) in psoriatic sera.

Authors:  K Ohkohchi; H Takematsu; H Tagami
Journal:  Br J Dermatol       Date:  1985-08       Impact factor: 9.302

10.  Expression of the interleukin-2 receptor (Tac antigen/CD25) in hematologic neoplasms.

Authors:  W N Erber; D Y Mason
Journal:  Am J Clin Pathol       Date:  1988-05       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.